Immix Biopharma Berita Eulerpool

Immix Biopharma Eulerpool News

Immix Biopharma Berita Saham

Immix Biopharma diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Immix Biopharma kami rangkum di sini.

• 29 Agustus ·

  Yahoo
  Immix Biopharma Independent Director Acquires 2.6% More Stock
• 28 Agustus ·

  Yahoo
  Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
• 28 Agustus ·

  Thefly.com
  Immix Biopharma announces three more sites for NEXICART-2 trial
• 19 Agustus ·

  Yahoo
  What Makes Immix Biopharma (IMMX) a New Buy Stock
• 19 Agustus ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)
• 12 Agustus ·

  InvestorPlace
  IMMX Stock Earnings: Immix Biopharma Beats EPS for Q2 2024
• 26 Juli ·

  TipRanks
  Buy Rating Affirmed: NXC-201’s Promising Clinical Trials and Strategic CIRM Grant Propel Positive Outlook
• 26 Juli ·

  Thefly.com
  Immix Biopharma awarded $8M CLIN2 grant
• 26 Juli ·

  Yahoo
  California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial (NEXICART-2)
• 8 Juli ·

  Yahoo
  Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201